CDH1 and pancreatic neoplasm: Circ-0013587 increases the level of E-cadherin by decreasing the expression of miR-1227, thus reversing the erlotinib resistance in pancreatic cancer cells and inhibiting the proliferation and EMT of pancreatic cancer cells [98].